Theralink (THER) 10-Q 14 Jan 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Nov. 30, 2013	Jan. 14, 2014
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Nov-13	'
Trading Symbol	'pedx	'
Entity Registrant Name	'QUINT MEDIA INC.	'
Entity Central Index Key	'0001362703	'
Current Fiscal Year End Date	'--02-28	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	62,833,000
Entity Current Reporting Status	'Yes	'
Entity Voluntary Filers	'No	'
Entity Well Known Seasoned Issuer	'No	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'

Balance_Sheets

Balance Sheets (USD $)	Nov. 30, 2013	Feb. 28, 2013
Current Assets	'	'
Cash and cash equivalents	$62,452	$512,484
Prepaid expenses	4,680	22,635
Total Current Assets	67,132	535,119
Website and website development cost	348,800	0
Assets from discontinued operations	200,000	250,556
Total Assets	615,932	785,675
Current Liabilities	'	'
Accounts payable and accrued liabilities	127,508	104,728
Accounts payable and accrued liabilities, related party	207,006	0
Short-term notes payable	400,000	500,000
Liabilities from discontinued operations	121,268	119,382
Total current liabilities	855,782	724,110
Stockholders' equity (deficit)	'	'
Capital stock Authorized 450,000,000 common shares, par value $0.0001 Issued and outstanding February 28, 2013 - 62,508,000 common shares November 30, 2013 - 62,883,000 common shares	6,288	6,251
Additional paid-in capital	2,697,541	2,622,578
Deficit accumulated during the development stage	-2,943,679	-2,567,264
Total stockholders' equity (deficit)	-239,850	61,565
Total liabilities and stockholders' equity (deficit)	$615,932	$785,675

Balance_Sheets_Parenthetical

Balance Sheets (Parenthetical) (USD $)	Nov. 30, 2013	Feb. 28, 2013
Common Stock, Shares Authorized	450,000,000	450,000,000
Common Stock, Par Value Per Share	$0.00	$0.00
Common Stock, Shares, Issued	62,883,000	62,508,000
Common Stock, Shares, Outstanding	62,883,000	62,508,000

Statement_of_Operations

Statement of Operations (USD $)	3 Months Ended		9 Months Ended		104 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013
Net revenues	$0	$0	$0	$0	$0
Expenses	'	'	'	'	'
Professional fees	83,528	13,189	197,748	123,564	759,221
Salaries and wages	0	35,970	0	277,213	654,204
General and administrative	79,137	0	150,699	0	1,089,666
Total Expenses	162,665	49,159	348,447	400,777	2,503,091
Other Income (Expenses)	'	'	'	'	'
Interest Expense	-6,575	-14,959	-24,668	-31,081	-111,471
Other income	55	0	622	0	622
Net Loss From Continuing Operations	-169,185	-64,118	-372,493	-431,858	-2,613,940
Income (Loss) From Discontinued Operations	2,388	-259,468	-3,922	686,945	-329,739
Net Income (Loss)	($166,797)	($323,586)	($376,415)	$255,087	($2,943,679)
Basic and diluted loss per common share from continuing operations	$0	$0	($0.01)	($0.01)	'
Basic and diluted income (loss) per common share from discontinued operations	$0	$0	$0	$0.01	'
Basic and diluted income (loss) per common share	$0	$0	($0.01)	$0	'
Weighted average number of common shares	62,528,604	62,508,000	62,514,818	62,508,000	'

Statement_of_Cash_Flows

Statement of Cash Flows (USD $)	9 Months Ended		104 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013
Cash Flows From Operating Activities	'	'	'
Net income (loss)	($376,415)	$255,087	($2,943,679)
Items to reconcile net loss to net cash used in operating activities:	'	'	'
Contributions to capital by related parties - expenses	0	0	58,799
Contributions to capital by related party - forgiveness of debt	0	0	38,950
Common shares issued for services	0	0	30
Stock based compensation	0	132,138	346,050
(Increase) decrease in prepaid expenses and deposits	17,955	-5,377	-4,680
Increase in accounts payable and accrued liabilities, related party	207,006	0	207,006
Increase (decrease) in accounts payable and accrued liabilities	22,780	-235,571	244,423
Net cash provided by (used in) continuing operations	-128,674	146,277	-2,053,101
Net cash provided by (used in) discontinued operations	52,442	-496,478	-142,512
Net cash used in operating activities	-76,232	-350,201	-2,195,613
Cash Flows From Investing Activities	'	'	'
Acquisition of SlickX and Flawsome	-50,000	0	-50,000
Capitalized website and website development costs	-298,800	0	-298,800
Net cash used in continuing investing activities	-348,800	0	-348,800
Net cash provided (used) in discontinued investing activities	0	123,464	-53,135
Net cash provided by (used in) investing activities	-348,800	123,464	-401,935
Cash Flows From Financing Activities	'	'	'
Proceeds from issuance of promissory notes	100,000	0	805,000
Principal payments on promissory notes	-200,000	0	-200,000
Common shares returned to treasury	0	0	-5,000
Proceeds from issuance of common stock	75,000	0	2,060,000
Cash provided by (used in) financing activities	-25,000	0	2,660,000
Increase (decrease) in cash and cash equivalents	-450,032	-226,737	62,452
Cash and cash equivalents, beginning of period	512,484	258,140	0
Cash and cash equivalents, end of period	62,452	31,403	62,452
Noncash investing activity	'	'	'
Apricus Biosciences, Inc. common stock received in consideration for termination of merger agreement	$0	$0	$1,000,000

Nature_of_Operations_Continuan

Nature of Operations, Continuance of Business, and Basis of Presentation	9 Months Ended
	Nov. 30, 2013
Nature of Operations, Continuance of Business, and Basis of Presentation [Text Block]	'
	1	Nature of Operations, Continuance of Business, and Basis of Presentation
		The accompanying unaudited condensed financial statements of Quint Media, Inc. (formerly PediatRx Inc.) (the “Company” or “Quint”) have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission, or the SEC, including the instructions to Form 10-Q and Regulation S-X. In the opinion of the management of Quint, all adjustments, which are of a normal recurring nature, necessary for a fair statement of the results for the three month periods and for the period from the date of inception have been made. Results for the interim periods presented are not necessarily indicative of the results that might be expected for the entire fiscal year. When used in these notes, the terms “Company”, “we” , “us” or “our” mean Quint Media, Inc. Certain information and note disclosure normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America has been condensed or omitted from these statements pursuant to such accounting principles and, accordingly, they do not include all the information and notes necessary for comprehensive financial statements and should be read in conjunction with our audited financial statements for the year ended February 28, 2013.
		From the date of its acquisition of Granisol ® (granisetron #C1) oral solution (“Granisol”), on July 23, 2010, until early this year, Quint engaged in the pharmaceutical business. Quint has decided to divest itself of the balance of its pharmaceutical assets and engage in the digital media business. Quint has evaluated Granisol and believes that upon sale Quint will be able to receive the net realizable value of $200,000 net of any commissions as currently stated on the balance sheet as of November 30, 2013.
		Quint is in the process of transitioning to its new operating business, digital media. The digital media business encompasses entrance into the social discovery aspects of the internet, primarily through the development of an engagement website with mobile and tablet applications. Quint capitalizes costs of licenses for the use of Internet domain names or Universal Resource Locators, website development costs, other information technology licenses and marketing and technology related intangibles. All such assets are capitalized at their original cost and upon substantial completion, will be amortized over their estimated useful.
		Effective August 7, 2013, Quint effected a three-for-one forward stock split of our authorized, and issued and outstanding shares of common stock. Authorized common stock increased from 150,000,000 shares of common stock to 450,000,000 shares of common stock, and issued and outstanding capital increased from 20,836,000 shares of common stock to 62,508,000 shares of common stock. All references to Quint common stock have been retroactively restated to reflect the effect of the forward split.

Going_Concern

Going Concern	9 Months Ended
	Nov. 30, 2013
Going Concern [Text Block]	'
	2	Going Concern
		Quint’s financial statements as of November 30, 2013 have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. Quint has a net loss of $376,415 for the nine month period ended November 30, 2013 and a cumulative deficit of $2,943,679 at November 30, 2013. The losses from operations of Quint raise substantial doubt about Quint’s ability to continue as a going concern. Management cannot provide assurance that Quint will ultimately achieve profitable operations or become cash flow positive, or raise additional debt and/or equity capital. Management believes that Quint’s capital resources are not currently adequate to continue operating and maintaining its business strategy for the fiscal year ending February 28, 2014. Quint will seek to raise capital through additional debt and/or equity financings to fund its operations in the future. Although Quint has historically raised capital from sales of equity and from the issuance of promissory notes, there is no assurance that it will be able to continue to do so. If Quint is unable to raise additional capital or secure additional lending in the near future, management expects that Quint will need to curtail or cease operations. These unaudited financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should Quint be unable to continue as a going concern.
		As of November 30, 2013, Quint was in the process of transitioning to its new operating business and expects to incur operating losses for the next twelve months as it moves forward. This new operating business encompasses entrance into the social discovery aspects of the internet; primarily development of an engagement website with mobile and tablet application.

Related_Party_Transactions

Related Party Transactions	9 Months Ended
	Nov. 30, 2013
Related Party Transactions [Text Block]	'
	3	Related Party Transactions
		On March 8, 2013, the Company entered into a Business Development/Advisory Services Agreement with Phys Pharma LLC, a company of which Dr. Durrant is a principal, pursuant to which Phys Pharma agreed to provide the Company a list of select biopharmaceutical companies which might have an interest in acquiring Granisol and assist the Company in marketing and selling Granisol to the prospective purchasers. If the Company sells Granisol to the prospective purchaser introduced by Phys Pharma, the Company agreed to pay Phys Pharma a fee in an amount equal to 20% of the net proceeds received by the Company at closing.
		On April 5, 2013, and pursuant to a purchase and sale agreement dated for reference March 5, 2013, Dr. Cameron Durrant, our former President, Chief Executive Officer and director, sold to Constantin Dietrich, a director of our company, 12,750,000 shares of our common stock for total consideration of $51,000. Mr. Dietrich paid the $51,000 purchase price for these shares using cash on hand. In addition, Mr. Dietrich assumed all of Dr. Durrant’s obligations under the Lock-Up Agreement between Dr. Durrant and our company dated February 9, 2011, pursuant to which 8,499,999 of the 12,750,000 shares sold by Dr. Durrant remain “locked up”. Our company has consented to the transfer of the shares and to the assignment and assumption of the obligations under the Lock-Up Agreement. Also on April 5, 2013, and pursuant to a purchase and sale agreement dated for reference March 8, 2013, David Tousley, our former Chief Financial Officer, Secretary, Treasurer and director, sold to Joseph Carusone, our Vice President, Investor Relations and a member of our Board of Directors, 1,200,000 shares of our common stock for total consideration of $9,600. Mr. Carusone paid the $9,600 purchase price for these shares using cash on hand. In addition, Mr. Carusone assumed all of Mr. Tousley’s obligations under the Lock-Up Agreement between Mr. Tousley and our company dated February 9, 2011, pursuant to which 799,998 of the 1,200,000 shares sold by Mr. Tousley remain “locked up”. Our company has consented to the transfer of the shares and to the assignment and assumption of the obligations under the Lock-Up Agreement.
		On May 17, 2013, the Company entered into a definitive Web Site Asset Purchase Agreement (the “Agreement”) with Lakefield Media Holding AG and its wholly-owned subsidiary, Flawsome XLerator GmbH (Flawsome). Constantin Dietrich, our current president and director of our company, is the founder and Chief Executive Officer of Lakefield Media Holding AG, which wholly-owns Flawsome.Pursuant to the Agreement, the Company acquired the internet domain name “Slickx.com”, the website and related software, intellectual property rights, accounts, contracts, goodwill and infrastructure for $50,000. This transaction was completed on May 21, 2013.
		On May 29, 2013 the Company entered into a consulting agreement with Flawsome, whereby Flawsome agreed to provide us with certain services, including general management, product management, requirements engineering, quality management, project management, design creation, development team lead, deployment management, content management, reporting services, web development, mobile development, basic content creation, server hosting and monitoring and update services. In return, we agreed to pay Flawsome a consulting fee on a monthly basis. The agreement will terminate on December 31, 2013 or can be terminated by either party with two months’ notice. During the nine months ended November 30, 2013, the Company capitalized $298,800 in development costs contracted through Flawsome related to the “Slickx.com” website. As of November 30, 2013, the Company owes $142,200 to Flawsome.
		As of November 30, 2013, the Company owes $64,806 for consulting services to a director and a Company whose shareholder is a director of the Company. The payable does not bear interest.

Shortterm_notes_payable

Short-term notes payable	9 Months Ended
	Nov. 30, 2013
Short-term notes payable [Text Block]	'
	4	Short-term notes payable
				November 30,		February 28,
				2013		2013
		Issued on June 15, 2009, this unsecured promissory note, originally bearing interest at five percent ( 5%) per annum on the principal balance of $50,000, was originally due on June 15, 2011. Effective May 18, 2011 this promissory note was amended whereby the maturity date of the note was extended until February 28, 2013. The promissory note is now past due and the principal amount or such portion thereof as shall remain outstanding from time to time shall accrue simple interest, calculated monthly in arrears, at a rate of 12% per annum commencing on the date of the promissory note and payable at maturity. Effective September 1, 2013, this promissory note was amended whereby the maturity date of the note was extended until June 30, 2014 and the interest rate was reduced to 7%.	$	50,000	$	50,000
		Issued on July 26, 2010, this unsecured promissory note, bearing interest at five percent ( 5%) per annum on the principal balance of $200,000, was originally due on July 26, 2011. Effective May 23, 2011 this promissory note was amended whereby the maturity date of the note was extended until February 28, 2013. The promissory note was paid in full in March 2013.		- 0 -		200,000
		Issued on May 6, 2011, this unsecured promissory note, originally bearing interest at five percent ( 5%) per annum on the principal balance of $250,000, was originally due on February 28, 2013. The promissory note is past due and the principal amount or such portion thereof as shall remain outstanding from time to time shall accrue simple interest, calculated monthly in arrears, at a rate of 12% per annum commencing on the date of the promissory note and payable at maturity. Effective September 1, 2013, this promissory note was amended whereby the maturity date of the note was extended until June 30, 2014 and the interest rate was reduced to 7%.		250,000		250,000
		Issued on September 24, 2013, this unsecured promissory note, bears interest at seven percent ( 7%) per annum on the principal balance of $100,000 and is due on June 30, 2014.		100,000		-
		Total Promissory Notes	$	400,000	$	500,000
	As of November 30, 2013, Quint entered into an amendment of a previously amended unsecured promissory note originally dated June 15, 2009 in the principal amount of $50,000. Effective September 1, 2013, the maturity date of the note has been extended from December 31, 2012 until June 30, 2014 and the interest rate on the outstanding principal balance has been decreased from twelve percent per annum to seven percent per annum. All other terms of the promissory note remain the same.
	In addition, as of November 30, 2013, we entered into an amendment of a previously amended unsecured promissory note originally dated May 6, 2011 in the principal amount of $250,000. Effective September 1, 2013, the maturity date of the note has been extended from December 31, 2012 until June 30, 2014 and the interest rate on the outstanding principal balance has been decreased from twelve percent per annum to seven percent per annum. All other terms of the promissory note remain the same.
		The Company determined that concessions granted in the form of extensions of the due dates and reductions in interest rates on these above mentioned promissory notes are considered debt modifications as defined under Accounting Standards Codification 470-60, “Troubled Debt Restructurings by Debtors”.
		Accrued interest on promissory notes payable totaled $69,282 and $78,968 at November 30, 2013 and February 28, 2013, respectively.

Discontinued_Operations

Discontinued Operations	9 Months Ended
	Nov. 30, 2013
Discontinued Operations [Text Block]	'
	5	Discontinued Operations
		During the period ended November 30, 2013, the Company’s management elected to discontinue the operations of its pharmaceutical business, divest itself of the balance of its pharmaceutical assets and engage in the digital media business. As such, all assets, liabilities and expenses of the pharmaceutical business have been presented as discontinued operations in the consolidated financial statements. A summary of those assets and liabilities as of November 30, 2013 and February 28, 2013 and revenues and expenses as of November 30, 2013 and 2012 and from Inception March 18, 2005 through November 30, 2013:
				November 30,			February 28,
				2013			2013
		Assets from discontinued operations
		Accounts receivable, net of reserves		-			50,556
		Intangible assets, net (available for sale)		200,000			200,000
		Total Assets	$	200,000		$	250,556
		Liabilities from discontinued operations
		Accounts payable and accrued liabilities	$	121,268		$	119,382
														For the Period from
			For the Three Months						For the Nine Months					Inception on March 18,
			Ended November 30,						Ended November 30,					2005 Through
			2013			2012			2013			2012		30-Nov-13
	Net revenues	$	6,310		$	-		$	6,310		$	120,640	$	1,131,517
	Expenses
	Cost of goods sold					1,152			6,310			36,276		363,081
	Amortization expense		-			20,214			-			64,355		682,820
	Consulting fees		1,611			242			1,611			3,276		632,797
	Write down of mineral property acquisition costs		-			-			-			-		5,000
	Management fees		-			-			-			-		48,000
	Mineral property rights		-			-			-			-		15,124
	Marketing		2,311			30,949			2,311			46,883		631,659
	General and administrative		-			34,718						110,712		-
	Total Expenses		3,922			87,275			10,232			261,502		2,378,481
	Other Income (Expenses)
	Gain on sale of product rights		-			-			-			-		64,900
	Other income (expense)		-			(172,193	)					827,807		852,325
	Net Income (Loss) From Discontinued Operations	$	2,388		$	(259,468	)	$	(3,922	)	$	686,945	$	(329,739	)

Common_Stock_and_Common_Stock_

Common Stock and Common Stock Warrants	9 Months Ended
	Nov. 30, 2013
Common Stock and Common Stock Warrants [Text Block]	'
	6	Common Stock and Common Stock Warrants
		On November 25, 2013, the Company sold 375,000 units of our securities at a price of $0.20 per unit for gross proceeds of $75,000. Each unit consists of one share of common stock and one non-transferable common stock purchase warrant, with each common stock purchase warrant entitling the holder to acquire one additional share of our common stock at a price of $0.50 per share for a period of 60 months.

Shortterm_notes_payable_Tables

Short-term notes payable (Tables)	9 Months Ended
	Nov. 30, 2013
Schedule of Debt [Table Text Block]	'
				November 30,		February 28,
				2013		2013
		Issued on June 15, 2009, this unsecured promissory note, originally bearing interest at five percent ( 5%) per annum on the principal balance of $50,000, was originally due on June 15, 2011. Effective May 18, 2011 this promissory note was amended whereby the maturity date of the note was extended until February 28, 2013. The promissory note is now past due and the principal amount or such portion thereof as shall remain outstanding from time to time shall accrue simple interest, calculated monthly in arrears, at a rate of 12% per annum commencing on the date of the promissory note and payable at maturity. Effective September 1, 2013, this promissory note was amended whereby the maturity date of the note was extended until June 30, 2014 and the interest rate was reduced to 7%.	$	50,000	$	50,000
		Issued on July 26, 2010, this unsecured promissory note, bearing interest at five percent ( 5%) per annum on the principal balance of $200,000, was originally due on July 26, 2011. Effective May 23, 2011 this promissory note was amended whereby the maturity date of the note was extended until February 28, 2013. The promissory note was paid in full in March 2013.		- 0 -		200,000
		Issued on May 6, 2011, this unsecured promissory note, originally bearing interest at five percent ( 5%) per annum on the principal balance of $250,000, was originally due on February 28, 2013. The promissory note is past due and the principal amount or such portion thereof as shall remain outstanding from time to time shall accrue simple interest, calculated monthly in arrears, at a rate of 12% per annum commencing on the date of the promissory note and payable at maturity. Effective September 1, 2013, this promissory note was amended whereby the maturity date of the note was extended until June 30, 2014 and the interest rate was reduced to 7%.		250,000		250,000
		Issued on September 24, 2013, this unsecured promissory note, bears interest at seven percent ( 7%) per annum on the principal balance of $100,000 and is due on June 30, 2014.		100,000		-
		Total Promissory Notes	$	400,000	$	500,000

Discontinued_Operations_Tables

Discontinued Operations (Tables)	9 Months Ended
	Nov. 30, 2013
Schedule of Disposal Groups, Including Discontinued Operations, Balance Sheet Disclosures [Table Text Block]	'
				November 30,			February 28,
				2013			2013
		Assets from discontinued operations
		Accounts receivable, net of reserves		-			50,556
		Intangible assets, net (available for sale)		200,000			200,000
		Total Assets	$	200,000		$	250,556
		Liabilities from discontinued operations
		Accounts payable and accrued liabilities	$	121,268		$	119,382
Schedule of Disposal Groups, Including Discontinued Operations, Income Statement Disclosures [Table Text Block]	'
														For the Period from
			For the Three Months						For the Nine Months					Inception on March 18,
			Ended November 30,						Ended November 30,					2005 Through
			2013			2012			2013			2012		30-Nov-13
	Net revenues	$	6,310		$	-		$	6,310		$	120,640	$	1,131,517
	Expenses
	Cost of goods sold					1,152			6,310			36,276		363,081
	Amortization expense		-			20,214			-			64,355		682,820
	Consulting fees		1,611			242			1,611			3,276		632,797
	Write down of mineral property acquisition costs		-			-			-			-		5,000
	Management fees		-			-			-			-		48,000
	Mineral property rights		-			-			-			-		15,124
	Marketing		2,311			30,949			2,311			46,883		631,659
	General and administrative		-			34,718						110,712		-
	Total Expenses		3,922			87,275			10,232			261,502		2,378,481
	Other Income (Expenses)
	Gain on sale of product rights		-			-			-			-		64,900
	Other income (expense)		-			(172,193	)					827,807		852,325
	Net Income (Loss) From Discontinued Operations	$	2,388		$	(259,468	)	$	(3,922	)	$	686,945	$	(329,739	)

Nature_of_Operations_Continuan1

Nature of Operations, Continuance of Business, and Basis of Presentation (Narrative) (Details) (USD $)	1 Months Ended
	Aug. 31, 2013	Nov. 30, 2013	Aug. 07, 2013	Aug. 06, 2013	Feb. 28, 2013
Assets from discontinued operations	'	$200,000	'	'	$250,556
Stockholders' Equity Note, Stock Split, Conversion Ratio	3	'	'	'	'
Common Stock, Shares Authorized	'	450,000,000	450,000,000	150,000,000	450,000,000
Common Stock, Shares, Issued	'	62,883,000	62,508,000	20,836,000	62,508,000
Common Stock, Shares, Outstanding	'	62,883,000	62,508,000	20,836,000	62,508,000

Going_Concern_Narrative_Detail

Going Concern (Narrative) (Details) (USD $)	3 Months Ended		9 Months Ended		104 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013
Net Loss (Income)	$166,797	$323,586	$376,415	($255,087)	$2,943,679
Accumulated Deficit	$2,943,679	'	$2,943,679	'	$2,943,679

Related_Party_Transactions_Nar

Related Party Transactions (Narrative) (Details) (USD $)	9 Months Ended		104 Months Ended		1 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013	Feb. 28, 2013	31-May-13	Mar. 31, 2013	Apr. 30, 2013	Apr. 30, 2013	Nov. 30, 2013	Nov. 30, 2013
					Acquisition of Slickx [Member]	Phys Pharma LLC [Member]	Mr. Carusone [Member]	Mr. Dietrich [Member]	Flawsome [Member]	a Company whose shareholder is a director of the Company [Member]
									Website Development [Member]	Consulting [Member]
Referral fee percent	'	'	'	'	'	20.00%	'	'	'	'
Stock Issued During Period, Shares, Issued for Cash	'	'	'	'	'	'	1,200,000	12,750,000	'	'
Stock Issued During Period, Value, Issued for Cash	'	'	'	'	'	'	$9,600	$51,000	'	'
Common stock, locked-up	'	'	'	'	'	'	799,998	8,499,999	'	'
Acquisition of SlickX and Flawsome	50,000	0	50,000	'	50,000	'	'	'	'	'
Website and website development cost	348,800	'	348,800	0	'	'	'	'	298,800	'
Due to Related Parties, Current	'	'	'	'	'	'	'	'	$142,200	$64,806

Shortterm_notes_payable_Narrat

Short-term notes payable (Narrative) (Details) (USD $)	Nov. 30, 2013	Feb. 28, 2013	Nov. 30, 2013	Aug. 31, 2013	Feb. 28, 2013	Jun. 15, 2009	Nov. 30, 2013	Aug. 31, 2013	Feb. 28, 2013	6-May-11
			Unsecured Promissory Note Issued on June 15, 2009 [Member]	Unsecured Promissory Note Issued on June 15, 2009 [Member]	Unsecured Promissory Note Issued on June 15, 2009 [Member]	Unsecured Promissory Note Issued on June 15, 2009 [Member]	Unsecured Promissory Note Issued on May 6, 2011 [Member]	Unsecured Promissory Note Issued on May 6, 2011 [Member]	Unsecured Promissory Note Issued on May 6, 2011 [Member]	Unsecured Promissory Note Issued on May 6, 2011 [Member]
Promissory notes	$400,000	$500,000	$50,000	'	$50,000	$50,000	$250,000	'	$250,000	$250,000
Debt Instrument, Interest Rate, Stated Percentage	'	'	7.00%	12.00%	'	5.00%	7.00%	12.00%	'	5.00%
Accrued interest on promissory notes payable	$69,282	$78,968	'	'	'	'	'	'	'	'

Common_Stock_and_Common_Stock_1

Common Stock and Common Stock Warrants (Narrative) (Details) (USD $)	1 Months Ended
	Nov. 30, 2013
Units issued	375,000
Price per unit	$0.20
Proceeds from units issued	$75,000
Price per share	$0.50
Class of Warrant or Right, Grants in Period, Contractual Term	'60 months

Schedule_of_Debt_Details

Schedule of Debt (Details) (USD $)

Nov. 30, 2013

Feb. 28, 2013

Nov. 30, 2013

Aug. 31, 2013

Feb. 28, 2013

Jun. 15, 2009

Nov. 30, 2013

Feb. 28, 2013

Jul. 26, 2010

Nov. 30, 2013

Aug. 31, 2013

Feb. 28, 2013

6-May-11

Nov. 30, 2013

Sep. 24, 2013

Feb. 28, 2013

Unsecured Promissory Note Issued on June 15, 2009 [Member]

Unsecured Promissory Note Issued on June 15, 2009 [Member]

Unsecured Promissory Note Issued on June 15, 2009 [Member]

Unsecured Promissory Note Issued on June 15, 2009 [Member]

Unsecured Promissory Note Issued on July 26, 2010 [Member]

Unsecured Promissory Note Issued on July 26, 2010 [Member]

Unsecured Promissory Note Issued on July 26, 2010 [Member]

Unsecured Promissory Note Issued on May 6, 2011 [Member]

Unsecured Promissory Note Issued on May 6, 2011 [Member]

Unsecured Promissory Note Issued on May 6, 2011 [Member]

Unsecured Promissory Note Issued on May 6, 2011 [Member]

Unsecured Promissory Note Issued on September 24, 2013 [Member]

Unsecured Promissory Note Issued on September 24, 2013 [Member]

Unsecured Promissory Note Issued on September 24, 2013 [Member]

Debt Instrument, Interest Rate, Stated Percentage

'

'

7.00%

12.00%

'

5.00%

'

'

5.00%

7.00%

12.00%

'

5.00%

'

7.00%

'

Promissory notes

$400,000

$500,000

$50,000

'

$50,000

$50,000

$0

$200,000

$200,000

$250,000

'

$250,000

$250,000

$100,000

$100,000

$0

Schedule_of_Disposal_Groups_In

Schedule of Disposal Groups, Including Discontinued Operations, Balance Sheet Disclosures (Details) (USD $)	Nov. 30, 2013	Feb. 28, 2013
Accounts receivable, net of reserves	$0	$50,556
Intangible assets, net (available for sale)	200,000	200,000
Total Assets	200,000	250,556
Accounts payable and accrued liabilities	$121,268	$119,382

Schedule_of_Disposal_Groups_In1

Schedule of Disposal Groups, Including Discontinued Operations, Income Statement Disclosures (Details) (USD $)	3 Months Ended		9 Months Ended		104 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013
Net revenues	$6,310	$0	$6,310	$120,640	$1,131,517
Cost of goods sold	'	1,152	6,310	36,276	363,081
Amortization expense	0	20,214	0	64,355	682,820
Consulting fees	1,611	242	1,611	3,276	632,797
Write down of mineral property acquisition costs	0	0	0	0	5,000
Management fees	0	0	0	0	48,000
Mineral property rights	0	0	0	0	15,124
Marketing	2,311	30,949	2,311	46,883	631,659
General and administrative	0	34,718	'	110,712	0
Total Expenses	3,922	87,275	10,232	261,502	2,378,481
Gain on sale of product rights	0	0	0	0	64,900
Other income	0	-172,193	'	827,807	852,325
Net Income (Loss) From Discontinued Operations	$2,388	($259,468)	($3,922)	$686,945	($329,739)